Regadenoson Injection, Solution
Product Images NDC 10135-803

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 10135-803). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pfs Carton (Regadenoson Pfs Carton)

Packaging label for Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) intravenous injection, solution. The label indicates a single-dose pre-filled syringe containing 5 mL, intended for pharmacologic stress agent use for diagnostic purposes only. Labeler is Marlex Pharmaceuticals, Inc., with NDC 10135-0803.*

FDA Label Image

Pfs Label (Regadenoson Pfs Label)

Label for Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) in a 5 mL single-dose pre-filled syringe. The label specifies use for pharmacologic stress only and intravenous administration. It includes handling instructions to discard unused portions and features manufacturing details for Indies Pharma Jamaica Limited, made in India, and a barcode. The label also displays the Marlex Pharmaceuticals, Inc. logo.*

FDA Label Image

Regadenoson-structure (Regadenoson Structure)

Chemical structure diagram of Regadenoson showing its molecular components and bonds as a detailed 2D chemical representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.